Giant Cell Tumor of Bone
Showing 9951 - 9975 of >10,000
Breast Cancer, Triple Negative Breast Cancer, Residual Cancer Trial in United States (Atezolizumab, Sacituzumab govitecan)
Recruiting
- Breast Cancer
- +3 more
- Atezolizumab
- Sacituzumab govitecan
-
San Francisco, California
- +8 more
May 25, 2022
Advanced Solid Tumor Trial in Tianjin (SHR-1802+camrelizumab + famitinib)
Recruiting
- Advanced Solid Tumor
- SHR-1802+camrelizumab + famitinib
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute&Hospital
May 25, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
-
Birmingham, Alabama
- +171 more
Aug 24, 2022
Complications After Hematopoietic Stem Cell Transplant
Recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Clinical Evaluation
- Electronic Health Record Review
-
Jacksonville, Florida
- +1 more
Mar 2, 2023
Stage III Locally Advanced Unresectable Non-small-cell Lung
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
- biomarker detection
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
Feb 7, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue
Recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Fairbanks, Alaska
- +671 more
Dec 29, 2021
Allogeneic Stell Cell Transplant, Viral Infection Trial in Cincinnati (Viral Specific T-cells (VSTs) Scheduled, Viral Specific
Recruiting
- Allogeneic Stell Cell Transplant
- Viral Infection
- Viral Specific T-cells (VSTs) Scheduled
- Viral Specific T-cells (VSTs) Treatment
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Mar 17, 2022
Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive, Plasmablastic Lymphoma Trial in United States (EPOCH-R,
Active, not recruiting
- Burkitt Lymphoma
- +2 more
-
La Jolla, California
- +29 more
Nov 2, 2021
Hematologic Malignancies Trial in Chicago (procedure, drug, radiation)
Terminated
- Hematologic Malignancies
- Haploidentical Transplant
- +4 more
-
Chicago, IllinoisUniversity of Illinois Cancer Center
Feb 12, 2020
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (tafasitamab, parsaclisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
-
Birmingham, Alabama
- +49 more
Sep 21, 2022
Circulating Tumor DNA From LIquid Biopsy in Early Stage NSCLC
Terminated
- Non Small Cell Lung Cancer
- biospecimen collection
-
Atlanta, Georgia
- +5 more
Nov 18, 2020
Rotator Cuff Tears Trial in Fargo, Sioux Falls (Adipose-derived stem cells, cortisone injection)
Completed
- Rotator Cuff Tears
- Adipose-derived stem cells
- cortisone injection
-
Fargo, North Dakota
- +1 more
Aug 2, 2022
Living Conditions After Non-Hodgkin's Lymphoma in France
Not yet recruiting
- Non-hodgkin's Lymphoma
- Data collection
- Questionnaires
-
Dijon, FranceChu Dijon Bourgogne
Oct 13, 2022
NSCLC Stage III Trial in Hefei (Envafolimab)
Not yet recruiting
- Non-small Cell Lung Cancer Stage III
-
Hefei, Anhui, ChinaAnhui Provincial Cancer Hospital
Jun 8, 2022
Hepatocellular Carcinoma (HCC) Trial in Japan, Taiwan (ERY974, Tocilicumab, Atezolizumab)
Recruiting
- Hepatocellular Carcinoma (HCC)
- ERY974
- +3 more
-
Chiba-shi, Chiba, Japan
- +5 more
Jun 22, 2022
Gastric Cancer, Esophageal Cancer, Stomach Cancer Trial in Saint Louis (CA-4948, 5-FU, Leucovorin)
Not yet recruiting
- Gastric Cancer
- +4 more
- CA-4948
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 27, 2022
Breast Cancer Trial in Brazil (No axillary surgery, SLNB)
Recruiting
- Breast Cancer
- No axillary surgery
- SLNB
-
Fortaleza, CE, Brazil
- +13 more
Apr 6, 2022
Ischemic Heart Failure, Chronic Heart Failure Trial in Changsha, Nanjing (Human (allogeneic) iPS-cell-derived cardiomyocyte)
Not yet recruiting
- Ischemic Heart Failure
- Chronic Heart Failure
- Human (allogeneic) iPS-cell-derived cardiomyocyte
-
Changsha, Hunan, China
- +1 more
Oct 12, 2022
Graft-versus-host Disease, Poor Graft Function, Low Donor T-cell Chimerism Trial in Belgium, Netherlands (Mesenchymal stem
Recruiting
- Graft-versus-host Disease
- +2 more
- Mesenchymal stem cells
-
Edeghem, Antwerpen, Belgium
- +11 more
Sep 19, 2022
Cognitive Burden Trial in Chapel Hill (Artificial Intelligence)
Not yet recruiting
- Cognitive Burden
- Artificial Intelligence
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Aug 29, 2023
Adenocarcinoma of Lung Trial in United States (NovoTTF-200T System)
Not yet recruiting
- Adenocarcinoma of Lung
- NovoTTF-200T System
-
Basking Ridge, New Jersey
- +6 more
Mar 3, 2023
Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in
Active, not recruiting
- Dedifferentiated Liposarcoma
- +5 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022